Caution must, however, be exercised interpreting data examining the contribution of neutrophils to protection in the later-phase infection when using immunocompetent mice as we have demonstrated direct binding of mAb RB6-8C5 to virus-specific CD8+ T cells and these cells may also be depleted as a result of RB6-8C5 treatment. The gene discussed is CD8A; the disease is infection.